Showing results (91-100 of 146) with videos related to
Sort By:
Pageof 15
Blood Cancer Journal|September 13, 2024
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patientsNisha S Joseph, Jonathan L Kaufman, Vilas A Gupta, et al.Plos One|June 4, 2010
Heterozygosity for Pten promotes tumorigenesis in a mouse model of medulloblastomaRobert C Castellino, Benjamin G Barwick, Matthew Schniederjan, et al.Clinical Lymphoma, Myeloma & Leukemia|April 27, 2019
Immunotherapy in Multiple Myeloma: Accelerating on the Path to the PatientIrene Ghobrial, Calixto Hernández Cruz, Alfred Garfall, et al.Blood|September 16, 2011
Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitorsPaola Neri, Li Ren, Kathy Gratton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2020
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple MyelomaNisha S Joseph, Jonathan L Kaufman, Madhav V Dhodapkar, et al.Blood|May 1, 2014
CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myelomaMegan E Murray, Catherine M Gavile, Jayakumar R Nair, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myelomaNizar J Bahlis, Jennifer McCafferty-Grad, Ileana Jordan-McMurry, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2011
CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironmentJayakumar R Nair, Louise M Carlson, Chandana Koorella, et al.ACS Nano|October 18, 2022
Inhibition of NADPH Oxidase-ROS Signal using Hyaluronic Acid Nanoparticles for Overcoming Radioresistance in Cancer TherapyLei Zhu, Yi Zhao, Tongrui Liu, et al.Blood|October 31, 2002
Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa BSubrata K Ghosh, Charles Wood, Lawrence H Boise, et al.Pageof 15